DNA 바코드를 기반으로 하여 외국발 국내 입항 선박에서 검출되는 편승자 해충(hitchhiker insect pests)에 대한 모니터링을 수행하였다. 국내 입항 선박 조사는 2018년 6월 1일부터 2018년 9월 17일까지 약 109일간 111개 선박에 대해 실시하였다. 모니터링 대상 해충은 ‘보고잡기법(simply collecting method by hands)’으로 확보하였으며, 총 336개체 에 대해 종동정을 실시하였다. 그 결과, 확보 해충 중 농림축산검역본부에 ‘관리해충(Regulated insect pest)’으로 등재되어 있는 Noctua pronuba를 포함하여 총 13종 21개체(Amata formosae (Erebidae, Lepidoptera, 1개체), Arippara disticha (Pyralidae, Lepidoptera, 1개체), Chondracris rosea (Acrididae, Orthoptera, 4개체), Cyrtacanthacris tatarica (Acrididae, Orthoptera, 1개체), Euhampsonia serratifera (Notodontidae, Lepidoptera, 3개체), Lemyra rhodophilodes (Erebidae, Lepidoptera, 2개체), Lymantria xylina (Erebidae, Lepidoptera, 1개체), Malacosoma dentata (Lasiocampidae, Lepidoptera, 3개체), Neochauliodes meridionalis (Corydalidae, Megaloptera, 1개체), Noctua pronuba (Noctuidae, Lepidoptera, 1개체), Parasa pastoralis (Limacodidae, Lepidoptera, 1개체), Psilogramma lukhtanovi (Sphingidae, Lepidoptera, 1개체), Syntypistis viridipicta (Notodontidae, Lepidoptera, 1개체))의 국내 미서식종이 채집되었으며, 확보된 21개체 중 15개체는 살아있는 상태로 검출되었다. 특히, 관리해충인 N. pronuba의 경우, 싱가포르에서 광양을 거쳐 포항항으로 입항한 선박에서 검출되었는데, 이 종은 유럽을 비롯하여 중동 및 중앙아시아까지 서식하는 종으로 1990년대 북미 대륙에 침입한 것으로 확인된 바 있다. 이에 따라, N. pronuba를 비롯하여 현 조사에 확인된 국내 미서식 편승자 해충의 편승 유무에 대한 정밀 모니터링 뿐만 아니라 위 종들에 대한 체계적인 위험성 평가 역시 필요할 것으로 사료된다.

The aim of this study was to evaluate the role of demineralized and particulate autogenous tooth, and interleukin-6 in bone regeneration. A demineralized and particulate autogenous tooth was prepared and human osteoblast-like cells (MG63) and human osteosarcoma cells were inoculated into the culture. The rate of cell adhesion, proliferation and mineralization were examined, and the appearance of cellular attachment was observed. An 8 mm critical size defect was created in the cranium of rabbits. Nine rabbits were divided into three groups including: An experimental group A (3 rabbits), in which a demineralised and particulate autogenous tooth was grafted; an experimental group B (3 rabbits), in which a demineralized, particulate autogenous tooth was grafted in addition to interleukin-6 (20 ng/mL); and a control group. The rabbits were sacrificed at 1, 2, 4 and 6 weeks for histopathological examination with H-E and Masson’s Trichrome, and immunohistochemistry with osteocalcin. The cell-based assay showed a higher rate of cell adhesion, mineralization and cellular attachment in the experimental group A compared with the control group. The animal study revealed an increased number of osteoclasts, newly formed and mature bones in the experimental group A compared with the control group. Eventually, a higher number of osteoclasts were observed in the experimental group B. However, the emergence of newly formed and mature bone was lower than in the experimental group A. The current results suggest that treatment with demineralized and particulate autogenous tooth and interleukin-6 is not effective in stimulating bone regeneration during the bone grafting procedure.

Opioid receptors have been pharmacologically classified as µ, δ, κ and ε. We have recently reported that the antinociceptive effect of morphine (a µ-opioid receptor agonist), but not that of β-endorphin (a novel µ/ε-opioid receptor agonist), is attenuated by whole body irradiation (WBI). It is unclear at present whether WBI has differential effects on the antinociceptive effects of µ-, δ-, κ- and ε-opioid receptor agonists. In our current experiments, male ICR mice were exposed to WBI (5Gy) from a 60 Co gamma-source and the antinociceptive effects of opioid receptor agonists were assessed two hours later using the hot water (52℃) tail-immersion test. Morphine and D-Ala2,N-Me-Phe4,Gly-ol-enkephalin (DAMGO), [D-Pen2-D-Pen5]enkephalin (DPDPE), trans-3,4-Dichloro-N-methyl-N-[2-(1-pyrrolidinyl)- cyclohexyl]¬benzeneacetamide (U50,488H), and β-endorphin were tested as agonists for µ, δ, κ, and ε-opioid receptors, respectively. WBI significantly attenuated the antinociceptive effects of morphine and DAMGO, but increased those of β-endorphin. The antinociceptive effects of DPDPE and U50,488H were not affected by WBI. In addition, to more preciously understand the differential effects of WBI on µ- and ε¬opioid receptor agonists, we assessed pretreatment effects of β-funaltrexamine (β-FNA, a µ-opioid receptor antagonist) or β-endorphin1-27 (β-EP1-27, an ε-opioid receptor antagonist), and found that pretreatment with β-FNA significantly attenuated the antinociceptive effects of morphine and β endorphin by WBI. significantly reversed the β-EP1-27 attenuation of morphine by WBI and significantly attenuated the increased effects of β-endorphin by WBI. The results demonstrate differential sensitivities of opioid receptors to WBI, especially for µ- and ε-opioid receptors.